1 MIN. DE LECTURA
ZURICH, June 20 (Reuters) - Swiss drugmaker Roche said on Monday its LightMix Modular Zika Virus Assay (CE) is available in markets accepting the CE mark for patients with signs and symptoms of the Zika infection where the virus is known to be present.
"The LightMix Modular Zika Virus Assay (CE) provides healthcare professionals an immediate option to detect the virus," Uwe Oberlaender, the head of Roche Molecular Diagnostics, said in a statement.
The virus has been associated with microcephaly, a birth defect characterized by an unusually small head and potential developmental problems. (Reporting by Joshua Franklin)